Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 1/20 | 0.51 |
| ▸ | RRM1 | P23921 | 2/20 | 0.51 |
| ▸ | RRM2B | Q7LG56 | 2/20 | 0.51 |
| ▸ | ALK | Q9UM73 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | F9 | P00740 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22801093 | 0.89 | KDM4E (0.52) | SCDRRM1RRM2BALKLMNA | |
| SCHEMBL22801025 | 0.85 | KDM4E (0.56) | SCDRRM1RRM2BLMNASMN1; SMN2 | |
| SCHEMBL21241972 | 0.78 | WNT3A (0.53) | PARP1 | |
| SCHEMBL4746841 | 0.77 | ALDH1A1 (0.63) | SCDRRM1RRM2BLMNASMN1; SMN2 | |
| SCHEMBL22801061 | 0.76 | SLC2A1 (0.48) | LMNASMN1; SMN2KDM4EMEN1ALDH1A1 | |
| SCHEMBL22971672 | 0.76 | MRE11 (0.44) | ALKMEN1KMT2A | |
| SCHEMBL22290360 | 0.76 | ABL1 (0.52) | SMN1; SMN2ALDH1A1MAPTHPGDHTT | |
| SCHEMBL16607166 | 0.76 | MAPT (0.70) | SCDLMNASMN1; SMN2KDM4EMEN1 | |
| SCHEMBL31173247 | 0.76 | ABL1 (0.52) | SMN1; SMN2ALDH1A1MAPTHPGDHTT | |
| SCHEMBL4741397 | 0.75 | RAB9A (0.56) | SCDRRM1RRM2BADORA3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200399264-A1 | 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS | NATIONAL INSTITUTES OF HEALTH | 2020-12-24 | — | — | US | disclosed |
| US-20200399264-A1 | 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS | NATIONAL INSTITUTES OF HEALTH | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200399264-A1 | 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS | MAVS, ZC3HAV1, EIF2AK2 | SCD 4612/4885RRM1 3494/4885RRM2B 3848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.